Rouven Wool-Lewis

Rouven Wool-Lewis, Ph.D., is an analyst at Durable Capital Partners LP, based in Ellicott City, Maryland. In this capacity, he focuses on the healthcare sector, leveraging scientific expertise to conduct equity research and identify investment opportunities in fields such as biotechnology, pharmaceuticals, and healthcare services. His core responsibilities include industry and company analysis, investment thesis development, and supporting portfolio decisions within Durable's healthcare strategy.

Prior to joining Durable Capital Partners LP in 2021, Dr. Wool-Lewis built a strong career in investment research and healthcare analysis at notable institutions including T. Rowe Price as an equity analyst, as well as earlier roles at Mars & Co, Oppenheimer, FBR Capital Markets, and UnitedHealth Group. He has been recognized for his in-depth sector knowledge and thorough approach to fundamental analysis, particularly in large-cap and growth equity strategies.

Dr. Wool-Lewis earned a B.A., magna cum laude with high honors, in biology and chemistry from Brandeis University and a Ph.D. in cellular and molecular biology from the University of Wisconsin–Madison. With over two decades of interdisciplinary experience, he is regarded for bridging scientific rigor with investment insight, and for his contributions to advancing healthcare-focused public equity investing.